All Stories

  1. Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC‐EHRA EORP Atrial Fibrillation Long‐Term General Registry

    Article • Journal of the American Heart Association, January 2025, Wolters Kluwer Health

    Prof. Francisco Marin , Nika Kuridze

  2. A prospective analysis of the efficacy and safety of ethacizine during premature atrial contractions and premature ventricular contractions

    Article • European Heart Journal, October 2024, Oxford University Press (OUP)

    Nika Kuridze

  3. Assessment of the Impact of Cardiac Implantable Electronic Devices on Patients' Quality of Life

    Article • Cureus, March 2024, Springer Science + Business Media

    Nika Kuridze

  4. Effectiveness and safety of direct oral anticoagulation vs. warfarin in frail patients with atrial fibrillation

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, November 2023, Oxford University Press (OUP)

    Nika Kuridze

  5. Tietze Syndrome as a Cause of Chest Pain in the Post-COVID-19 Period

    Article • Cureus, April 2023, Springer Science + Business Media

    Nika Kuridze

  6. Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry

    Article • European Journal of Internal Medicine, January 2023, Elsevier

    Prof. Francisco Marin , Nika Kuridze

  7. Left ventricular pseudoaneurysmectomy in patient without hemodynamic instability: A case report

    Article • Clinical Case Reports, January 2023, Wiley

    Nika Kuridze

  8. Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry

    Article • EP Europace, November 2022, Oxford University Press (OUP)

    Prof. Francisco Marin , Nika Kuridze

  9. Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry

    Article • European Journal of Internal Medicine, November 2022, Elsevier

    Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin , Nika Kuridze, Dr Radoslaw Lenarczyk

  10. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

    Article • BMC Medicine, September 2022, Springer Science + Business Media

    Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin , Nika Kuridze, Dr Radoslaw Lenarczyk

  11. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe

    Article • Age and Ageing, August 2022, Oxford University Press (OUP)

    Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin , Nika Kuridze, Dr Radoslaw Lenarczyk

  12. Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation ...

    Article • European Journal of Preventive Cardiology, June 2022, Oxford University Press (OUP)

    Nika Kuridze, Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  13. Technical difficulties during electronic cardiac device implantation in patients with persistent left superior vena cava

    Article • Heliyon, June 2022, Elsevier

    Nika Kuridze

  14. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry

    Article • European Journal of Internal Medicine, May 2022, Elsevier

    Nika Kuridze, Professor Tchavdar N Shalganov, Prof. Francisco Marin

  15. Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry

    Article • European Journal of Internal Medicine, May 2022, Elsevier

    Nika Kuridze, Prof. Francisco Marin

  16. Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general long‐term registry

    Article • European Journal of Clinical Investigation, March 2022, Wiley

    Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  17. Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry

    Article • European Journal of Clinical Investigation, January 2022, Wiley

    Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  18. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry

    Article • EP Europace, November 2021, Oxford University Press (OUP)

    Nika Kuridze, Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  19. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

    Article • BMC Medicine, October 2021, Springer Science + Business Media

    Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  20. Outcomes of digoxin vs. beta blocker in atrial fibrillation: report from ESC–EHRA EORP AF Long-Term General Registry

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, October 2021, Oxford University Press (OUP)

    Nika Kuridze, Prof. Francisco Marin

  21. Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF General Long-Term Registry

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, September 2021, Oxford University Press (OUP)

    Nika Kuridze

  22. Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry

    Article • Clinical Research in Cardiology, August 2021, Springer Science + Business Media

    Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  23. Iatrogenic tracheal rupture after extubation in the context of acute decompensated heart failure

    Article • Oxford Medical Case Reports, July 2021, Oxford University Press (OUP)

    Nika Kuridze

  24. Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry

    Article • EP Europace, October 2020, Oxford University Press (OUP)

    Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  25. Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, June 2020, Oxford University Press (OUP)

    Nika Kuridze, Dr Radoslaw Lenarczyk

  26. P426Routine use of transoesophageal echocardiography in patients with atrial fibrillation or atrial flutter undergoing cardioversion

    Article • EP Europace, June 2020, Oxford University Press (OUP)

    Nika Kuridze

  27. OUP accepted manuscript

    Article • EP Europace, January 2019, Oxford University Press (OUP)

    Professor Tchavdar N Shalganov, Nika Kuridze, Professor Erkin Mirrakhimov, Prof. Francisco Marin

  28. Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry

    Article • EP Europace, September 2017, Oxford University Press (OUP)

    Professor Tchavdar N Shalganov, Professor Erkin Mirrakhimov, Nika Kuridze, Prof. Francisco Marin